全球 IVF 市場規模、佔有率、成長分析（按產品類型、最終用途分類）—產業預測，2024-2031 年

Global In Vitro Fertilization Market Size, Share, Growth Analysis, By Product Type(Fresh Donor, Fresh Non-Donor), By End-use(Fertility Clinics, Surgical Centers) - Industry Forecast 2024-2031

出版日期: 2024年03月29日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球IVF市場規模為237.5億美元，從2023年的251億美元成長到2031年的391.1億美元，預測期間（2024-2031年）複合年成長率為5.7%。

輔助生殖技術（ART）市場涉及在體外使精子和卵子受精，稱為全球體外受精市場。體外受精是目前治療不孕症和幫助夫婦受孕的常用技術。 IVF涉及受精、取卵、卵巢刺激和胚胎移植等許多過程。體外受精的主要目的是幫助有懷孕困難的夫婦並提供健康懷孕的方法。當自然受孕不可能或不太可能成功時，就會使用體外受精 (IVF)。該市場為渴望成為父母但正在與不孕症作鬥爭的個人和夫婦提供解決方案。由於各種疾病、延遲懷孕、生活方式的改變和荷爾蒙失衡，世界各地不孕症的發生率不斷增加。由於實驗室技術、冷凍保存技術、基因檢測和胚胎選擇等技術的發展，體外受精（IVF）的成功率已顯著提高。尋求可靠和成功的生殖保健服務的夫婦被此類技術發展所吸引。接受試管嬰兒治療的夫婦常常面臨心理和生理上的艱難旅程。對某些個人和夫妻來說，密集的治療方法、未知的成功率和心理負擔可能是追求體外受精的障礙。開發中國家獲得生殖醫學的機會和可用選擇的知識正在不斷擴大。因此，這些地區的體外受精設施的開拓和市場的拓展具有潛力。這些可能性包括開發中國家需求的增加以及改善患者治療效果和成功率的技術進步。隨著新方法和策略的開發，試管受精產業不斷變化，為想要建立或擴大家庭的夫婦提供了選擇和希望。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 歐洲其他地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

CooperSurgical, Inc.（US）
Vitrolife AB（Sweden）
Cook Medical（US）
Irvine Scientific（US）
Merck KGaA（Germany）
Thermo Fisher Scientific, Inc.（US）
Esco Micro Pte Ltd（Singapore）
Genea Limited（Australia）
Ferring Pharmaceuticals（Switzerland）
Hamilton Thorne, Inc.（Canada）
Nidacon International AB（Sweden）
Rocket Medical plc（UK）
EMD Serono（US）
OvaScience（US）
Kitazato Corporation（Japan）
IVFtech Aps（Denmark）
Zeiss Group（Germany）
Igenomix（Spain）
Labotect GmbH（Germany）
Esco Medical（Singapore）

簡介目錄

Product Code: SQMIG35H2163

Global In Vitro Fertilization Market size was valued at USD 23.75 Billion in 2022 and is poised to grow from USD 25.10 Billion in 2023 to USD 39.11 Billion by 2031, at a CAGR of 5.7% during the forecast period (2024-2031).

The market for assisted reproductive technology (ART) treatments that entail fertilizing an egg with sperm outside of the human body is known as the global in vitro fertilization market. IVF is now a commonly used technique to treat infertility and help couples become pregnant. It includes a number of processes like fertilization, extraction of eggs, ovarian stimulation, and embryo transfer. The main goal of the IVF industry is to assist couples who are having trouble conceiving and provide them with a means of achieving a healthy pregnancy. When natural pregnancy is either impossible or unlikely to succeed, in vitro fertilization (IVF) is utilized. The market offers solutions to individuals and couples who want to become parents but are struggling with infertility. The incidence of infertility around the world have been increasing as a result of various diseases, delayed pregnancies, altered lifestyles, and hormonal imbalances. Success rates in in vitro fertilization (IVF) have increased dramatically due to technological developments in laboratory techniques, cryopreservation technologies, genetic testing, and embryo selection. Couples looking for dependable and successful reproductive treatments are drawn to these developments. Couples undergoing IVF therapy frequently face a difficult psychological and physical journey. For certain individuals or couples, the intense treatment regimen, unknown success rates, and psychological strain may serve as obstacles to pursuing in vitro fertilization. In developing nations, where access to reproductive treatments and knowledge of available options are expanding, there is a growing demand for IVF procedures. This offers chances for the development of IVF facilities in these areas and market expansion. Possibilities include the rising demand from developing nations and technology advancements that can enhance patient outcomes and success rates. As new methods and strategies are developed, the IVF industry keeps changing, giving couples looking to start or grow a family options and hope.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global In Vitro Fertilization Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global In Vitro Fertilization Market Segmental Analysis

The product, end-use, and geographic segments of the worldwide in vitro fertilization market are split up. The market is divided into four categories based on product: frozen donor, frozen non-donor, fresh donor, and fresh non-donor. Hospitals, surgery centers, research institutes, and fertility clinics make up the various end-user segments of the market. The market is divided into five regions: Latin America, Middle East and Africa, Asia Pacific, Europe, and North America.

Drivers of the Global In Vitro Fertilization Market

Significant improvements in the reproductive technologies utilized in IVF operations were made in 2021. Time-lapse imaging techniques, for example, have made it possible to continuously watch the growth of embryos, which has improved selection and increased success rates. More people and couples chose to undertake IVF treatments as a result of these developments.

Restraints in the Global In Vitro Fertilization Market

In 2021, the expense of IVF procedures continued to be a major barrier. Many individuals and couples find IVF unaffordable due to the high costs of medication, laboratory procedures, and several treatment cycles. This is especially true for those who lack sufficient financial resources or insurance coverage.

Market Trends of the Global In Vitro Fertilization Market

Growing Trend in Genetic Testing: Preimplantation genetic testing (PGT) and other genetic testing methods were becoming more and more popular in IVF treatments in 2022. By enabling the screening of embryos for genetic abnormalities prior to implantation, PGT lowers the risk of genetic problems in kids and increases the likelihood of successful pregnancies.

Growing Emphasis on Personalized Medicine: In the IVF industry, personalized medicine became more well-known in 2021. The strategy entails customizing IVF treatment plans according to the unique characteristics of each patient, including age, ovarian reserve, and unique reproductive issues. The goal of personalized medicine is to increase the effectiveness of IVF treatments and maximize treatment results.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global In Vitro Fertilization Market by Product Type

Market Overview
Fresh Donor
Fresh Non-Donor
Frozen Donor
and Frozen Non-Donor

Global In Vitro Fertilization Market by End-use

Market Overview
Fertility Clinics
Surgical Centers
Hospitals
Research Institutes

Global In Vitro Fertilization Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

CooperSurgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esco Micro Pte Ltd (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hamilton Thorne, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nidacon International AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rocket Medical plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EMD Serono (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OvaScience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kitazato Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IVFtech Aps (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zeiss Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Igenomix (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Labotect GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esco Medical (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments